JP2023538614A5 - - Google Patents

Info

Publication number
JP2023538614A5
JP2023538614A5 JP2023512178A JP2023512178A JP2023538614A5 JP 2023538614 A5 JP2023538614 A5 JP 2023538614A5 JP 2023512178 A JP2023512178 A JP 2023512178A JP 2023512178 A JP2023512178 A JP 2023512178A JP 2023538614 A5 JP2023538614 A5 JP 2023538614A5
Authority
JP
Japan
Prior art keywords
formula
compound
salt
process according
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023512178A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023538614A (ja
JP7778135B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/046286 external-priority patent/WO2022040172A1/en
Publication of JP2023538614A publication Critical patent/JP2023538614A/ja
Publication of JP2023538614A5 publication Critical patent/JP2023538614A5/ja
Application granted granted Critical
Publication of JP7778135B2 publication Critical patent/JP7778135B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023512178A 2020-08-18 2021-08-17 Jak1阻害剤を調製するためのプロセス及び中間体 Active JP7778135B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063067062P 2020-08-18 2020-08-18
US63/067,062 2020-08-18
PCT/US2021/046286 WO2022040172A1 (en) 2020-08-18 2021-08-17 Process and intermediates for preparing a jak1 inhibitor

Publications (3)

Publication Number Publication Date
JP2023538614A JP2023538614A (ja) 2023-09-08
JP2023538614A5 true JP2023538614A5 (cg-RX-API-DMAC10.html) 2025-10-31
JP7778135B2 JP7778135B2 (ja) 2025-12-01

Family

ID=77693614

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023512178A Active JP7778135B2 (ja) 2020-08-18 2021-08-17 Jak1阻害剤を調製するためのプロセス及び中間体

Country Status (18)

Country Link
US (2) US11897889B2 (cg-RX-API-DMAC10.html)
EP (1) EP4200278A1 (cg-RX-API-DMAC10.html)
JP (1) JP7778135B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230095923A (cg-RX-API-DMAC10.html)
CN (1) CN117043152A (cg-RX-API-DMAC10.html)
AR (1) AR123268A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021329301A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023002939A2 (cg-RX-API-DMAC10.html)
CA (1) CA3192055A1 (cg-RX-API-DMAC10.html)
CL (2) CL2023000482A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023003286A2 (cg-RX-API-DMAC10.html)
CR (1) CR20230130A (cg-RX-API-DMAC10.html)
EC (1) ECSP23019419A (cg-RX-API-DMAC10.html)
IL (1) IL300557A (cg-RX-API-DMAC10.html)
MX (1) MX2023002035A (cg-RX-API-DMAC10.html)
PE (1) PE20231308A1 (cg-RX-API-DMAC10.html)
TW (1) TWI904215B (cg-RX-API-DMAC10.html)
WO (1) WO2022040172A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11992490B2 (en) 2019-10-16 2024-05-28 Incyte Corporation Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)
IL300555A (en) 2020-08-18 2023-04-01 Incyte Corp Process and intermediates for preparing a JAK inhibitor
CA3192055A1 (en) 2020-08-18 2022-02-24 Incyte Corporation Process and intermediates for preparing a jak1 inhibitor
CA3226714A1 (en) 2021-07-12 2023-01-19 Incyte Corporation Process and intermediates for preparing baricitinib
CN117903032A (zh) * 2022-10-12 2024-04-19 重庆博腾制药科技股份有限公司 一种巴瑞替尼中间体的制备方法及制备巴瑞替尼的方法
CN120882718A (zh) * 2023-03-17 2025-10-31 北京普祺医药科技股份有限公司 吡咯并嘧啶化合物或其可药用盐的制备方法
CN121135621A (zh) * 2024-06-07 2025-12-16 上海长森药业有限公司 一种jak抑制剂的制备方法及其中间体

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB812366A (en) 1955-08-18 1959-04-22 Wellcome Found Improvements in and relating to derivatives of pyrimidine and the preparation thereof
US5102904A (en) 1989-12-08 1992-04-07 American Cyanamid Company N-oxygenated arylpyrrole insecticidal, acaricidal and nematicidal agents and use thereas
WO2003013518A1 (en) * 2001-08-03 2003-02-20 Smithkline Beecham Corporation Alpha-ketoamide derivatives as cathepsin k inhibitors
WO2004021979A2 (en) 2002-09-06 2004-03-18 Smithkline Beecham Corporation PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS
JP4842929B2 (ja) 2004-05-27 2011-12-21 ファイザー・プロダクツ・インク 癌治療に有用なピロロピリミジン誘導体
AR054416A1 (es) 2004-12-22 2007-06-27 Incyte Corp Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
WO2007012953A2 (en) 2005-07-29 2007-02-01 Pfizer Products Inc. Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
HUE028588T2 (hu) 2005-12-13 2016-12-28 Incyte Holdings Corp Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
CN2928286Y (zh) 2006-01-06 2007-08-01 水城钢铁(集团)有限责任公司 预入口导卫装置
HRP20120786T1 (hr) 2006-02-02 2012-11-30 Millennium Pharmaceuticals, Inc. Inhibitori aktivirajuä†eg enzima e1
WO2007129195A2 (en) 2006-05-04 2007-11-15 Pfizer Products Inc. 4-pyrimidine-5-amino-pyrazole compounds
EP2740731B1 (en) 2007-06-13 2016-03-23 Incyte Holdings Corporation Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
CL2008001709A1 (es) 2007-06-13 2008-11-03 Incyte Corp Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
BRPI0815042A2 (pt) 2007-08-01 2015-02-10 Pfizer Compostos de pirazol
EA020777B1 (ru) 2007-11-16 2015-01-30 Инсайт Корпорейшн 4-пиразолил-n-арилпиримидин-2-амины, 4-пиразолил-n-пиразолилпиримидин-2-амины и 4-пиразолил-n-пиридилпиримидин-2-амины в качестве ингибиторов киназ janus
MY165582A (en) 2008-03-11 2018-04-05 Incyte Holdings Corp Azetidine and cyclobutane derivatives as jak inhibitors
CL2009001884A1 (es) 2008-10-02 2010-05-14 Incyte Holdings Corp Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
WO2010083283A2 (en) 2009-01-15 2010-07-22 Incyte Corporation Processes for preparing jak inhibitors and related intermediate compounds
CA2756250A1 (en) 2009-04-10 2010-10-14 Pfizer Inc. 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
NZ596479A (en) 2009-05-22 2014-01-31 Incyte Corp N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
BRPI1012108B8 (pt) 2009-05-22 2021-05-25 Incyte Corp composto 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octa no- ou heptano-nitrila, sua composição, seus usos e processo para preparar um sal de ácido fosfórico
TW201113285A (en) 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
EA021478B1 (ru) 2009-10-09 2015-06-30 Инсайт Корпорейшн ГИДРОКСИЛЬНЫЕ, КЕТО И ГЛЮКУРОНИДНЫЕ ПРОИЗВОДНЫЕ 3-(4-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1Н-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА
JP2013510166A (ja) 2009-11-06 2013-03-21 プレキシコン インコーポレーテッド キナーゼ調節のための化合物、方法およびその適用
EP2501236B1 (en) 2009-11-18 2017-03-29 Plexxikon Inc. N-[2-fluoro-3-(4-amino-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-phenyl]-4-benzenesulfonamide derivatives as Raf protein kinase modulators for the treatment of cancer
US20110207754A1 (en) 2010-02-18 2011-08-25 Incyte Corporation Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
CA2792508C (en) 2010-03-10 2018-01-16 Incyte Corporation Piperidin-4-yl azetidine derivatives as jak1 inhibitors
TWI510487B (zh) 2010-04-21 2015-12-01 Plexxikon Inc 用於激酶調節的化合物和方法及其適應症
EA202091303A3 (ru) 2010-05-21 2021-05-31 Инсайт Холдингс Корпорейшн Композиция ингибитора jak для местного применения
CA2818542A1 (en) 2010-11-19 2012-05-24 Incyte Corporation Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
ES2536415T3 (es) 2010-11-19 2015-05-25 Incyte Corporation Pirrolopiridinas y pirrolopirimidinas sustituidas heterocíclicas como inhibidores de JAK
US8691807B2 (en) 2011-06-20 2014-04-08 Incyte Corporation Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
BR112014002472A2 (pt) 2011-08-12 2017-04-11 Nissan Chemical Ind Ltd "compostos heterocíclicos tricíclicos, seu uso, agente terapêutico para reumatismo articular e medicamento"
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為jak抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
EP2628730B1 (en) 2012-02-16 2017-12-06 Noxell Corporation Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1h-pyrazole salts
TW201406761A (zh) 2012-05-18 2014-02-16 Incyte Corp 做爲jak抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
KR102242077B1 (ko) 2012-11-15 2021-04-20 인사이트 홀딩스 코포레이션 룩솔리티니브의 서방성 제형
CN103044286B (zh) * 2013-01-25 2015-04-08 重庆紫光化工股份有限公司 丙二腈的合成方法
EP3489239B1 (en) * 2013-03-06 2021-09-15 Incyte Holdings Corporation Processes and intermediates for making a jak inhibitor
CR20190156A (es) 2013-05-17 2019-05-16 Incyte Corp Derivados de bipirazol como inhibidores jak
MX376856B (es) 2013-08-07 2025-03-07 Incyte Holdings Corp Formas de dosificacion de liberacion prolongada para un inhibidor de jak 1 (cinasa de janus 1).
SG11201609016VA (en) 2014-04-30 2016-11-29 Incyte Corp Processes of preparing a jak1 inhibitor and new forms thereto
ES2874537T3 (es) 2014-08-21 2021-11-05 Ratiopharm Gmbh Sal oxalato de ruxolitinib
WO2016026975A1 (en) 2014-08-21 2016-02-25 Ratiopharm Gmbh Salt of (r)-3-(4-(7h-pyrrolo [2,3-d] pyrimidin-4-yl)-lh-pyrazol-l-yl)-3-cyclopentylpropanenitrile with benzenesulfonic acid
WO2016035014A1 (en) 2014-09-01 2016-03-10 Sun Pharmaceutical Industries Limited Processes for the preparation of ruxolitinib phosphate
WO2016063294A2 (en) 2014-10-20 2016-04-28 Msn Laboratories Private Limited Process for the preparation of (r)-3-(4-(7h-pyrrolo[2,3-d], pyrimidin-4-yl)-1 h-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate and its polymorphs thereof
JP6038111B2 (ja) * 2014-12-27 2016-12-07 ヤマサ醤油株式会社 多置換7−デアザプリン誘導体合成のための2,6−ジクロロ−8−ヨード−7−デアザプリン
EA031895B1 (ru) 2015-02-24 2019-03-29 Пфайзер Инк. Замещенные нуклеозидные производные, полезные в качестве агентов против рака
CA2928286A1 (en) 2015-04-28 2016-10-28 Signa S.A. De C.V. Solid form of ruxolitinib phosphate
CN106397443A (zh) 2015-07-17 2017-02-15 浙江九洲药业股份有限公司 一种吡咯嘧啶类衍生物中间体的制备方法
CZ2015575A3 (cs) 2015-08-26 2017-03-08 Zentiva, K.S. Soli 5-fluoro-3-fenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]quinazolin-4-onu a jejich příprava
ES2954596T3 (es) 2015-12-23 2023-11-23 Univ British Columbia Profármacos unidos a lípidos
ES2882118T3 (es) 2015-12-31 2021-12-01 Chia Tai Tianqing Pharmaceutical Group Co Ltd Procedimiento de síntesis de ruxolitinib
CZ201629A3 (cs) 2016-01-22 2017-08-02 Zentiva, K.S. Krystalické modifikace solí (3R)-3-cyklopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propannitrilu a způsoby jejich přípravy
CN107513069A (zh) 2016-06-16 2017-12-26 正大天晴药业集团股份有限公司 手性吡咯并嘧啶化合物的制备方法
IN201641026603A (cg-RX-API-DMAC10.html) 2016-08-04 2018-02-09
CN107722012B (zh) 2016-08-11 2020-05-29 斯福瑞(南通)制药有限公司 制备4-氯-7H-吡咯并[2,3-d]嘧啶的方法
CN107759623B (zh) 2016-08-23 2020-08-14 苏州旺山旺水生物医药有限公司 Jak抑制剂的中间体及其制备方法
CN107759601B (zh) 2016-08-23 2020-09-11 苏州旺山旺水生物医药有限公司 一种jak抑制剂及其盐的制备方法
EP3515909A1 (en) 2016-09-23 2019-07-31 Cellipse Lim kinase inhibitors, pharmaceutical composition and method of use in limk-mediated diseases
CN109651424B (zh) 2017-10-11 2021-01-22 新发药业有限公司 一种7-保护基-4-(1-氢-吡唑-4-基)吡咯[2,3-d]嘧啶的合成方法
CN109867675B (zh) * 2017-12-01 2021-01-19 北京普祺医药科技有限公司 一种吡咯并嘧啶衍生的化合物、药物组合物以及其用途
US10766900B2 (en) 2017-12-29 2020-09-08 Formosa Laboratories, Inc. Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof
MD3746429T2 (ro) 2018-01-30 2022-08-31 Incyte Corp Procedee pentru prepararea de (1-(3-fluoro-2-(trifluorometil)izonicotinil)piperidin-4-onă)
CN112041303A (zh) 2018-05-21 2020-12-04 Pi工业有限公司 制备取代的杂环化合物的方法
EP3921318A1 (en) 2019-02-06 2021-12-15 Concert Pharmaceuticals Inc. Process for preparing enantiomerically enriched jak inhibitors
CN110724145A (zh) 2019-11-01 2020-01-24 廖文杰 一种医药中间体4-氯吡咯并嘧啶的合成方法
IL300555A (en) 2020-08-18 2023-04-01 Incyte Corp Process and intermediates for preparing a JAK inhibitor
CA3192055A1 (en) 2020-08-18 2022-02-24 Incyte Corporation Process and intermediates for preparing a jak1 inhibitor
CN116761792A (zh) * 2020-08-18 2023-09-15 因赛特公司 用于制备jak抑制剂的方法和中间体
CA3226714A1 (en) 2021-07-12 2023-01-19 Incyte Corporation Process and intermediates for preparing baricitinib
CN113480546A (zh) 2021-07-30 2021-10-08 江苏君若药业有限公司 巴瑞克替尼及其衍生物的制备

Similar Documents

Publication Publication Date Title
JP7431312B2 (ja) ピロリジノン及びこれらを調製するためのプロセス
JP5934182B2 (ja) 4−{4−[({[4−クロロ−3−(トリフルオロメチル)フェニル]アミノ}カルボニル)アミノ]−3−フルオロフェノキシ}−n−メチルピリジン−2−カルボキサミド、その塩及び一水和物の製造方法
US8558000B2 (en) 4-pyridinone compounds and their use for cancer
CZ297862B6 (cs) Meziprodukty a zpusob výroby derivátu camptothecinu (CPT-11) a príbuzných sloucenin
JP6062050B2 (ja) フルオロピコリノイルフルオライドおよびそれらの調製方法
JP2008508309A (ja) ピリドンカルボン酸抗菌薬の調製
WO2022228535A1 (zh) 烟碱及其中间体的制备方法
JP6239003B2 (ja) 4−アミノ−5−フルオロ−3−クロロ−6−(置換)ピコリネートの調製方法
JP2008525486A (ja) 置換ピペリジンの製造方法
EP4140992B1 (en) Method for preparing s-nicotine
CN113387925B (zh) 一种由戊二酸酯合成s-尼古丁的制备方法
JP5095945B2 (ja) 4−トリフルオロメチルニコチン酸又はその塩の製造方法
JP2006070034A (ja) 2−アミノピリジン誘導体の製造方法
KR100971371B1 (ko) 신규한 중간체를 이용한 보리코나졸의 제조방법
WO2014020467A2 (en) Process for the preparation of pyrazole substituted aminoheteroaryl compounds
JP7373241B2 (ja) ピリミジニルビピリジン化合物の製造方法及びそのための中間体
US9611250B2 (en) Process for preparing 4-(cyclopropylmethoxy)-N-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide
JP2006001882A (ja) O−置換チロシン化合物の製造方法
JP2016508512A (ja) ビス−ジハロアルキルピラゾールの製造方法
JP6961595B2 (ja) 4−アルコキシ−3−トリフルオロメチルベンジルアルコールの製造方法
JP4381220B2 (ja) 殺菌性ピリジン化合物の製造方法
JP2003321468A (ja) ピリドン化合物の製造法およびその中間体
JP2005504791A (ja) 4−ハロアルキルニコチン酸エステルの製造
CZ302270B6 (cs) 1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)fenyl]ethanon a zpusob jeho výroby
KR20200143796A (ko) 싸이오아우론계 화합물의 제조방법